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Type I interferon (IFN) is crucial during infection
through its antiviral properties and by coordinating
the immunocompetent cells involved in antiviral or
antibacterial immunity. Type I IFN (IFN-a and IFN-b)
is produced after virus or bacteria recognition by
cytosolic receptors or membrane-bound TLR re-
ceptors following the activation of the transcription
factors IRF3 or IRF7. IFN-b production after fungal
infection was recently reported, although the under-
lying mechanism remains controversial. Here we
describe that IFN-b production by dendritic cells
(DCs) induced by Candida albicans is largely depen-
dent on Dectin-1- and Dectin-2-mediated signaling.
Dectin-1-induced IFN-b production required the
tyrosine kinase Syk and the transcription factor
IRF5. Type I IFN receptor-deficient mice had a lower
survival after C. albicans infection, paralleled by
defective renal neutrophil infiltration. IFN-b produc-
tion by renal infiltrating leukocytes was severely
reduced in C. albicans-infected mice with Syk-defi-
cient DCs. These data indicate that Dectin-induced
IFN-b production by renal DCs is crucial for defense
against C. albicans infection.
INTRODUCTION
The type I interferon (IFN) cytokine family includes IFN-b and 14
members of the IFN-a family (Decker et al., 2005). Type I IFN was
originally discovered by its antiviral properties, which rely primar-
ily on its capacity to block gene translation, to inhibit viral replica-1176 Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc.tion, to trigger the production of nucleases degrading viral
nucleic acids, and to induce the apoptosis of infected cells
(Stetson and Medzhitov, 2006). However, type I IFN was subse-
quently demonstrated to play also a crucial role during infection
by coordinating the function of different immunocompetent cells
involved in the induction of defense against viruses and intracel-
lular bacteria. In this regard, type I IFN can license dendritic cells
(DCs) for cross-priming-dependent activation of CD8+ T cells,
trigger the effector function of cytotoxic CD8+ T cells, activate
natural killer (NK) cells through interleukin-15 (IL-15) production,
and promote the production of leukocyte-attractant chemokines
(Gonza´lez-Navajas et al., 2012). Type I IFN can be produced after
recognition of viruses or intracellular bacteria through two cate-
gories of receptors: ubiquitously expressed cytosolic receptors
such as RIG-I and MDA5 (that sense viral dsRNA), or NOD1
and NOD2 (that sense bacterial peptidoglycans), and mem-
brane-bound Toll-like receptors (TLRs), such as TLR3, TLR4,
TLR7, and TLR9 (Trinchieri, 2010). These type I IFN-inducing
TLRs that are selectively expressed by specialized immunocom-
petent cells are located at the cell surface (TLR4, that senses
Gram-negative bacteria LPS) or at endosomal compartments
(TLR3, TLR7, and TLR9, that sense viral or bacterial nucleic
acids). After viral or bacterial infection, the engagement of type
I IFN-inducing receptors, except TLR7 and TLR9, leads to the
activation of the transcription factor IFN response factor 3
(IRF3) that induces the production of IFN-b and IFN-a4 (Trin-
chieri, 2010). In contrast, engagement of endosomal TLR7 and
TLR9 in DCs leads to the production of IFN-b and all types of
IFN-a by a mechanism dependent on the transcription factor
IRF7 (Decker et al., 2005; refer to Figure S7 available online for
an integrated view of type I IFN-inducing receptors).
Recent studies have revealed that type I IFN can be produced
by DCs in response to fungi, particularly to yeasts of the genus
Candida (Biondo et al., 2011; Bourgeois et al., 2011), which
can cause life-threatening infections in immunocompromised
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCspatients (Pfaller and Diekema, 2007). As described for bacterial
infections, type I IFN can be beneficial for the immune response
to yeast, as described for Candida albicans (Biondo et al., 2011),
or have a detrimental effect, as reported for Candida glabrata
infection (Bourgeois et al., 2011). However, the mechanism
bywhich type I IFN is produced duringCandida infection remains
controversial. Activation of DCs after interaction with C. albicans
has been claimed to result from the engagement of TLR2 and
TLR9, and particularly of Dectin-1 (Clec7a; Romani, 2011), a
C-type lectin receptor recognizing the complex b-glucan cell
wall of C. albicans, that is crucial for the induction of protective
T helper 17 (Th17) cell responses (LeibundGut-Landmann
et al., 2007). Dectin-1 engagement results in the recruitment of
Syk, that leads to the activation of PLCg2 (Xu et al., 2009) and
to the assembly of the Card9 complex by a mechanism depen-
dent on PKCd (Strasser et al., 2012). Dectin-1-triggered Card9
signaling then drives IL-1b, IL-2, IL-6, IL-10, IL-12, IL-23, and
tumor necrosis factor-a (TNF-a) production by an NF-kB and
NFAT-dependent pathway (Sancho and Reis e Sousa, 2012;
refer to Figure S7 for an integrated view of Dectin-1-mediated
signaling).
In order to explore the involvement of Dectin-1 in the produc-
tion of type I IFN during fungal infection, we have analyzed the
signaling pathway controlling IFN-b expression by DCs in
response to C. albicans. Our data have allowed us to describe
a pathway leading to IFN-b production by DCs that depends
on Dectin-1 and Dectin-2 activation. Dectin-1-induced IFN-b
production was dependent on Syk- and Card9-driven signaling
and on the transcription factor IRF5 and independent of IRF3
and IRF7. Experiments of in vivo infection with C. albicans per-
formed in mice deficient in the IFNAR1 subunit of the type I IFN
receptor IFN-a and IFN-b receptor-deficient (Ifnar1/) and
CD11c-Cre+/ Sykfl/fl mice, in which DCs are not responsive to
Syk-dependent signaling, demonstrated that type I IFN exerted
a protective role duringC. albicans infection and that the produc-
tion of type I IFN by renal leukocytic infiltrates was mainly
controlled by DCs through Dectin-1 and Dectin-2 signaling.
Taken together, our results support the hypothesis that the
production of type I IFN by renal infiltrating DCs, mediated by
Dectin-Syk-IRF5 signaling, plays a crucial role in defense against
C. albicans infection.
RESULTS
Dectin-1 Engagement Induces IFN-b Production by
Dendritic Cells
In order to address the involvement of Dectin-1 in the production
of type I IFN by DCs, we first assessed by real-time PCR the
capacity of bone-marrow-derived DCs (BMDCs) to express
IFN-b-specific messenger RNA (mRNA) in response to Curdlan
(awater-insoluble b-1,3 polysaccharide fromAlcaligenes faecalis
that acts as a Dectin-1 specific ligand), to Zymosan (a complex
insoluble preparation from Saccharomyces cerevisiae that acti-
vates TLR2 and TLR6, TLR9, and Dectin-1), to heat-killed
C. albicans, strain SC5314 (HKC), and to LPS from Escherichia
coli, that was used as a control of type I IFN production in
response to TLR4. Engagement of TLR4 was characterized by
a fast and transient induction of IFN-b mRNA, which peaked
2 hr after LPS stimulation and returned to basal levels along thenext 4 hr. In contrast, Curdlan and Zymosan induced amore sus-
tained expression of IFN-b mRNA, which peaked at 3 hr, was
maintained at maximal levels until 5 hr, and was still detectable
8 hr after stimulation (Figure 1A). The kinetics of IFN-b mRNA
expression after stimulation with HKC revealed a slower
response peaking at 5 hr. This delayed response compared to
Curdlan or Zymosan could reflect a reduced exposure of DC-
activating Candida-associated molecular patterns by HKC, and
consequently a less efficient recognition of these ligands by the
TLRs and C-type lectin receptors expressed by BMDCs.
One possible explanation for this sustained IFN-b mRNA
expression is that IFN-b produced after engagement of Dectin-1
and/or TLRs by yeast compounds present in Curdlan and/or
Zymosan triggers, in an autocrine manner, the signaling through
the type I IFN receptor (IFNAR) IFN-a and IFN-b receptor
(IFNAR1). This would lead to a feed-forward loop of IFN-b pro-
duction that has been described for TLR7- or TLR-9-activated
plasmacytoid DCs (Decker et al., 2005) but that was not opera-
tional in BMDCs activated by LPS (Figure S1). However, no dif-
ferences in IFN-b mRNA expression were observed between
Ifnar1/ and wild-type (WT) BMDCs after stimulation with
Curdlan or Zymosan (Figure S1). These results indicates that
IFNAR signaling did not contribute to a feed-forward loop of
IFN-b production in BMDCs under these activation conditions,
although the autocrine IFNAR signaling pathway was operational
because no expression of mRNA for the IFN-inducible antiviral
gene Mx2 was detected in Ifnar1/ BMDCs (Figure S1). There-
fore the sustained IFN-b mRNA expression induced by Curdlan
and Zymosan was not due to IFNAR signaling, but most likely
to a Dectin-1-specific transcriptional regulation of Ifnb gene
expression, as discussed below.
As stated before, IRF3-mediated IFN-b production resulting
from the recognition of viral or bacterial compounds by type I
IFN-inducing cytosolic or TLR receptors has been claimed to
be paralleled by IFN-a4 production (Trinchieri, 2010). To address
whether this also occurred in response to C. albicans, we
analyzed IFN-a mRNA expression in BMDCs stimulated with
Curdlan or Zymosan by real-time PCR, by using pan-IFN-a
primers. IFN-a mRNA expression was not detected in BMDCs
stimulated with Curdlan or Zymosan (Figure S2). In contrast,
IFN-a mRNA was induced in bone marrow-derived macro-
phages (BMMs) stimulated with either Curdlan or Zymosan (Fig-
ure S2A), indicating that Curdlan-induced signaling can lead to
the induction of IFN-a mRNA, although this appears to be cell-
type-specific. Interestingly, Curdlan or Zymosan stimulation
induced a significantly higher IFN-bmRNA expression in BMDCs
than in BMMs (Figure S2B).
To confirm that IFN-b production in response to Curdlan was
due to Dectin-1 engagement, the expression of IFN-b mRNA
and the production of IFN-b was analyzed by real-time PCR
and ELISA, respectively, after stimulation of BMDCs from
Dectin-1 deficient (Clec7a/) mice (Figures 1B and 1C).
Whereas no difference in the expression of mRNA for IFN-b
was observed between WT and Clec7a/ BMDCs stimulated
with LPS (Figure 1B), IFN-b mRNA expression was dramatically
reduced in Clec7a/ BMDCs after Curdlan stimulation (Fig-
ure 1B), and, correspondingly, no IFN-b was detected at the
protein level (Figure 1C). This result demonstrates that the pro-
duction of IFN-b by Curdlan-stimulated BMDCs was dependentImmunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc. 1177
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Figure 1. Dectin-1 Engagement Induces
IFN-b Production by BMDCs
(A) Expression of mRNA for IFN-b by BMDCs
stimulated for the indicated times with Curdlan,
Zymosan, HKC, or LPS was assessed by real-time
PCR, normalized to b-actin.
(B) BMDCs from WT or Clec7a/ mice, un-
stimulated or stimulated for 2 or 5 hr with Curdlan,
Zymosan, HKC, or LPS, were analyzed for the
expression of mRNA for IFN-b by real-time PCR,
normalized to b-actin.
(C) IFN-b production by BMDCs from WT or
Clec7a/ mice unstimulated (control) or stimu-
lated for 16 hr with Curdlan, Zymosan, HKC, or
LPS, was analyzed by ELISA.
(D and E) IFN-bmRNA expression by BMDCs from
WT, Tlr2/ (D), or Tlr9/ (E) mice stimulated for
5 hr with Curdlan, Zymosan, or HKC was analyzed
by real-time PCR, normalized to b-actin. Real-time
PCR data are expressed as induction fold relative
to unstimulated controls (mean ± SD of triplicates).
ELISA data are expressed as mean ± SD of
duplicate samples. The values for unstimulated
controls were below the detection level of the
ELISA kit used in this study (15.6 pg/ml), nd: not
detectable. Significant differences, as determined
by the unpaired t test, are indicated *p < 0.05; **p <
0.01; ***p < 0.001. Data are representative of at
least two independent experiments with similar
results. See also Figures S1 and S2.
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCson Dectin-1 signaling. After stimulation with Zymosan or HKC,
IFN-b mRNA expression was significantly lower in Clec7a/
that in WT BMDCs (Figure 1B), and, accordingly, IFN-b produc-
tion was reduced around 80% (Figure 1C). These data suggest
that IFN-b production in response to C. albicans results, for the
most part, from Dectin-1 signaling, and consequently to a lesser
extent from TLR-mediated signaling. To further explore the
relative contribution of TLR-mediated signaling to IFN-b produc-
tion in response to C. albicans, we analyzed IFN-b mRNA
expression by BMDCs from mice deficient in the receptors
TLR2 or TLR9 that have been reported to contribute pre-
dominantly to TLR-mediated activation of DCs exposed to
C. albicans, by interacting with Candida cell wall mannans and
CandidaDNA, respectively (Romani, 2011). As expected, neither
TLR2 nor TLR9 deficiency affected the response of BMDCs to
Curdlan stimulation (Figures 1D and 1E). The expression of1178 Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc.IFN-b mRNA was reduced around 50%
after stimulation of Tlr2/ BMDCs with
HKC compared to their WT counterparts,
but was not significantly affected in HKC-
stimulated BMDCs from Tlr9/ mice.
This result reflects that Candida DNA
does not contribute significantly to HKC-
mediated IFN-b production and revealed
that HKC preparations contained a
minimal amount of free Candida DNA.
In contrast, IFN-b mRNA expression
induced by Zymosan was strongly in-
hibited in Tlr9/ BMDCs, indicating that
yeast DNA from S. cerevisiae was readilyexposed in Zymosan preparations. Globally, these results reveal
that IFN-b production by BMDCs in response to C. albicans is
mainly driven by Dectin-1 signaling and that IFN-b produced
by BMDCs in response to Curdlan is TLR-independent and
dependent on Dectin-1.
IFN-bProduction Triggered byDectin-1 Is Dependent on
Syk and Card9
Asmentioned above, Dectin-1 engagement results in the recruit-
ment of Syk and Card9, leading to cytokine production by an
NF-kB and NFAT-dependent pathway (Sancho and Reis e
Sousa, 2012). In order to assess whether Dectin-1-induced
IFN-b production was dependent on Syk, IFN-b production
was analyzed in BMDCs from CD11c-Cre+/ Sykfl/fl mice, in
which Syk deletion is under the control of the promoter for
CD11c, an integrin expressed by all mouse DC subtypes. As
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Figure 2. Contribution of Syk and Card9
Signaling to IFN-b Production by BMDCs in
Response to C. albicans
(A and B) IFN-b production by BMDCs from WT,
CD11c-Cre+/ Sykfl/fl (A), or Card9/ (B) mice
unstimulated (control) or stimulated for 16 hr with
LPS, Curdlan, or HKC was analyzed by ELISA.
(C) IFN-b mRNA expression by BMDCs treated
with anti-Dectin-2 or isotype control antibodies
and stimulated for the indicated times with LPS,
Curdlan, or HKC was analyzed by real-time PCR,
normalized to b-actin.
(D) IFN-b production by BMDCs treated with anti-
Dectin-2 or isotype control antibodies and stimu-
lated or not (control) for 16 hr with LPS, Curdlan, or
HKC was analyzed by ELISA.
(E) IFN-b mRNA expression by BMDCs from
Clec4e/ mice stimulated for the indicated times
with LPS, Curdlan, or HKC was analyzed by real-
time PCR, normalized to b-actin.
(F) IFN-b production by BMDCs from Clec4e/
mice unstimulated (control) or stimulated for 16 hr
with LPS, Curdlan, or HKCwas analyzed by ELISA.
Real-time PCR data are expressed as induction
fold relative to unstimulated controls (mean ±SDof
triplicates). ELISA data are expressed as mean ±
SD of duplicate samples. Significant differences,
as determined by the unpaired t test, are indicated
*p < 0.05; **p < 0.01; ***p < 0.001. Data are repre-
sentative of at least two independent experiments
with similar results. n.d., not detectable.
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCsshown in Figure 2A, deletion ofSyk had no effect on the synthesis
of IFN-b by BMDCs stimulated by LPS as expected, but
completely blocked its production by Curdlan-stimulated
BMDCs, confirming the involvement of Syk in Dectin-1-mediated
IFN-b production. Because Card9 is involved in NF-kB activation
resulting from Dectin-1 engagement (Gross et al., 2006) and
NF-kB is required for the transcriptional activation of the Ifnb
gene (Panne et al., 2007), we hypothesized that Card9 could
also control IFN-b production in response toCurdlan. To address
this issue, we analyzed BMDCs from Card9/ mice for their
ability to produce IFN-b after stimulation with Curdlan or LPS.
As expected, Card9 deficiency strongly inhibited the production
of IFN-b in response to Curdlan, but not to LPS, confirming that
Dectin-1-mediated IFN-b production is dependent on Card9
(Figure 2B). Interestingly, IFN-b production by HKC-stimulated
BMDCs from either CD11c-Cre+/ Sykfl/fl or Card9/ mice
was barely detectable, indicating that production of IFN-b by
BMDCs in response to C. albicans is essentially dependent on
Syk and Card9 signaling.
The fact that the blockade of IFN-b production in response to
HKC was even more pronounced in either CD11c-Cre+/ Sykfl/fl
orCard9/ BMDCs than inClec7a/BMDCs, led us to explore
the contribution of Dectin-2 and Mincle, the two other C-type
lectin receptors recognizing C. albicans cell wall mannans and
signaling through a Syk-Card9-mediated pathway (Sancho
and Reis e Sousa, 2012), to IFN-b production in response toImmunity 38, 1176–118C. albicans. The production of IFN-b
in response to Curdlan was reduced
around 20% and 50% at the mRNA andprotein level, respectively, after treatment with the anti-Dectin-2
blocking antibody D2.11E4 (Figures 2C and 2D). This result sug-
gests that in BMDCs Curdlan was recognized by Dectin-2,
although less efficiently than by Dectin-1, or alternatively that
the Dectin-2 antibody D2.11E4 displayed some cross-reactivity
with Dectin-1. Interestingly, HKC-induced production of IFN-b
by anti-Dectin-2 treated BMDCs was reduced to a same extent
than in Clec7a/ BMDCs. In contrast, Mincle (Clec4e) defi-
ciency had no effect on IFN-b production induced by either
Curdlan or HKC (Figures 2E and 2F). These data suggest that
Dectin-2, which requires to be associated with the ITAM-bearing
adaptor FcRg to recruit Syk (Sancho and Reis e Sousa, 2012),
contributes significantly to IFN-b production in response to
C. albicans, through a Dectin-2-FcRg-Syk pathway. Therefore
our data support that IFN-b production in response to
C. albicans results essentially from the combined action of
Dectin-1 and Dectin-2 signaling.
IRF5, but Neither IRF3 Nor IRF7, Controls
Dectin-1-Dependent IFN-b Production
To identify themolecularmechanism leading to IFN-b production
after Dectin-1 engagement, we analyzed the activation of the
main transcriptional activators required for the assembly of the
IFN-b enhanceosome: NF-kB, c-Jun, and IRF3. For this purpose,
the phosphorylation and nuclear translocation of the RelA sub-
unit of NF-kB, c-Jun, and IRF3 was evaluated by immunoblot6, June 27, 2013 ª2013 Elsevier Inc. 1179
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Figure 3. Activation of Ifnb Gene Transcriptional Activators after
Dectin-1 Engagement in BMDCs
RelA, c-Jun, and IRF3 activation was determined on nuclear and cytosolic
protein extracts from BMDCs stimulated with LPS, Zymosan, or Curdlan for
2 hr. Extracts were analyzed by immunoblot by using antibodies against
phospho-RelA, phospho-c-Jun, or phospho-IRF3, RelA, c-Jun, and IRF3.
Purity of the nuclear and cytosolic cell fractions was assessed by using anti-
bodies against Histones (H1 and core proteins) and b-tubulin, respectively.
Data are representative of two independent experiments with similar results.
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Figure 4. IRF5, but Neither IRF3 Nor IRF7, Controls Dectin-1-
Dependent IFN-b Production
IFN-b production by BMDCs from wild-type (WT), Irf3/ (A), Irf7/ (B) or
Irf5/ (C) mice unstimulated (control) or stimulated for 16 hr with LPS or
Curdlan was analyzed by ELISA. Data are expressed as mean ± SD of dupli-
cate samples. Significant differences, as determined by the unpaired t test, are
indicated *p < 0.05; **p < 0.01. Data are representative of three (A) or two
(B and C) independent experiments with similar results. n.d., not detectable.
See also Figure S3.
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCson cell lysates from the nuclear or cytosolic fractions of Curdlan-,
Zymosan-, or LPS-activated BMDCs. Whereas BMDC stimula-
tion with either Curdlan, Zymosan, or LPS led to a correct
activation of RelA (Figure 3), the phosphorylation and nuclear
translocation of c-Jun was almost undetectable in BMDCs acti-
vated with Curdlan, indicating that IFN-b production in response
to Curdlan occurred in the absence of a strong c-Jun activation.
In contrast, both Zymosan and LPS induced a correct activation
of c-Jun. The analysis of IRF3 activation, required for IFN-b pro-
duction in response to the majority of type I IFN-inducing recep-
tors, including cytosolic receptors as well as TLR3 and TLR4
(Trinchieri, 2010), revealed that IRF3 was not phosphorylated
and consequently it was not translocated to the nucleus in
response to Curdlan stimulation. In contrast, as expected, these
processes occurred correctly in LPS- or Zymosan-activated
BMDCs (Figure 3). This finding strongly supports the hypothesis
that IRF3 was not required for IFN-b production in response to
Curdlan. To confirm this hypothesis, we analyzed BMDCs from
Irf3/ mice for their capacity to produce IFN-b in response to
Curdlan or LPS. IRF3 deficiency led to a dramatic reduction in
IFN-b production by BMDCs stimulated with LPS, but had no
effect on the synthesis of IFN-b in response to Curdlan (Fig-
ure 4A), confirming that IRF3 was not involved in Dectin-1-trig-
gered IFN-b production. Given that IFN-b production induced
after engagement of TLR7 or TLR9 on DCs has been demon-
strated to be dependent on the transcription factor IRF7 (Decker
et al., 2005), we used BMDCs from Irf7/ mice to address
whether IRF7 was involved in Dectin-1-mediated IFN-b produc-
tion. Our data demonstrate that IRF7was not involved in this pro-
cess as IFN-b production by Curdlan-stimulated BMDCs was1180 Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc.not affected by IRF7 deficiency (Figure 4B). In conclusion, these
experiments confirmed that IFN-b production in response to
Curdlanwas dependent on neither IRF3 nor IRF7, that in contrast
play a crucial role in the control of type I IFN production in
response to virus and bacteria through cytosolic or TLR recep-
tors. In search for amember of the IRF family of transcription fac-
tors that may control the transcriptional activation of the Ifnb
gene resulting from Dectin-1 engagement, we explored the
possible involvement of IRF5 in this process, based on two
recent reports demonstrating a correlation between IRF5 and
IFN-b production after bacterial infection (Gratz et al., 2011; Pan-
dey et al., 2009). Interestingly, Dectin-1-mediated IFN-b produc-
tion was found to be strongly dependent on IRF5, as assessed
by analyzing BMDCs from Irf5/ mice (Figure 4C). Regarding
Immunity
Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCsthese experiments performed with Irf5/ mice, it is important to
point out that a recent report (Purtha et al., 2012) has revealed
that, in some cases, Irf5/mice harbor a spontaneous mutation
in the Dock2 gene that could interfere with the analysis of IRF5
deficiency. However, as shown in Figure S3, the genotyping of
the Irf5/ mice used in our study confirmed that they had a
normal Dock2 genotype.
In conclusion, our data firmly demonstrate the existence in
BMDCs of a Dectin-1-mediated signaling pathway leading to
the production of IFN-b that is dependent on the Syk kinase,
the NF-kB activator Card9 and on the transcription factor IRF5.
Importantly, our results also support that type I IFN production
by BMDCs in response to C. albicans is mainly controlled by
this Dectin-1-dependent pathway.
Type I IFN Production in Response to C. albicans Is
Crucial for Defense against Candidiasis
In order to explore the role of IFN-b produced in response to
C. albicans, we first analyzed the survival of WT versus Ifnar1/
mice after intravenous injection of LD50 dose of 1 3 10
5
C. albicans. During the 2 first weeks after infection, 100% (12/
12) versus 16% (2/12) mice died in Ifnar1/ and WT strains,
respectively. Correspondingly, the survival at day 30 after infec-
tion was significantly higher in WT than in Ifnar1/ mice (75%
versus 0%, p value < 0.0001; Figure 5A). Because the kidney is
the main target for C. albicans infection, we analyzed the renal
fungal burden at day 6 after infection, corresponding to the
time point when mice started to die. As expected from our sur-
vival data, Ifnar1/mice had a significantly higher fungal burden
than WT mice (p value < 0.05; Figure 5B). In line with our data
supporting that type I IFN production by DCs in response
to C. albicans is essentially dependent on Dectin-Syk-IRF5
signaling, the renal fungal load in C. albicans-infected Irf5/
mice was significantly higher than in their WT counterparts
(p value < 0.05; Figure S4). In an attempt to unravel the mecha-
nism by which IFN-b exerted a protective effect after
C. albicans infection, we analyzed the recruitment to the kidney
of the different leukocytic cell types infiltrating the renal paren-
chyma, in WT and Ifnar1/mice, from day 0 to day 6 after infec-
tion. The number of renal infiltrating leukocytes, characterized as
CD45+ cells, was reduced in Ifnar1/ mice to 50% and 15% of
controls at days 2 and 6 after infection, respectively (Figure 5C).
This was paralleled by an average 50% reduction in the number
of infiltrating NK cells, B cells, and DCs in Ifnar1/mice at day 2
postinfection. At day 6, the lymphoid and DC subsets underwent
a more pronounced reduction, to around 30% of controls for B
cells and DCs and to around 15% of controls for T cells and
NK cells (Figures 5D and 5E). Interestingly, the number of neutro-
phils present in renal leukocyte infiltrates of Ifnar1/ mice was
reduced to around 25%of controls at day 2 and underwent a dra-
matic 95% reduction at day 6. No reduction was detected in any
leukocyte-infiltrating subset at day 4 postinfection in line with
previous data revealing the existence of two waves of leukocyte
infiltration in the kidney afterC. albicans infection peaking at days
3 and 5 after infection (Lionakis et al., 2011). To determine
whether the impaired neutrophil recruitment to the kidney
observed in Ifnar1/ mice was linked to a defective expression
of neutrophil-attractant chemokines, we first analyzed the pro-
duction of CXCL1 and CXCL2 by CD45+ renal infiltrating leuko-cytes at themRNA and protein level, by real-time PCR and Lumi-
nex, respectively. In line with the strong reduction in the number
of neutrophils observed in the renal infiltrates of Ifnar1/ mice,
the production of CXCL1 and CXCL2 by renal infiltrating leuko-
cytes was also significantly reduced in Ifnar1/ mice (Figures
5G and 5H). Because nonhematopoietic cells are known to
contribute also substantially to the production of these chemo-
kines, we analyzed the expression of CXCL1 and CXCL2
mRNA by the CD45 nonhematopoietic kidney fraction in
C. albicans-infected WT and Ifnar1/ mice. Interestingly,
IFNAR1 deficiency did not affect the expression of these chemo-
kines by nonhematopoietic cells (Figure S5). These data suggest
that type I IFN promotes neutrophil recruitment to the kidney by a
process that involves CXCL1 and CXCL2 production by infil-
trating leukocytes. We subsequently explored the mechanism
by which type I IFN positively regulates the production of these
chemokines in the kidney during C. albicans infection. For this
purpose we analyzed the effect of IFNAR1 deficiency on the
expression of mRNA for CXCL1 and CXCL2 by BMDCs and neu-
trophils in vitro after stimulation with Curdlan or HKC, because
DCs and neutrophils are the main leukocytes subsets potentially
responsible for the production of theses chemokines in the kid-
ney after C. albicans infection. Our data revealed that whereas
no differences in CXCL1 and CXCL2 mRNA expression were
found between BMDCs fromWT or Ifnar1/mice, IFNAR1 defi-
ciency lead to a strong reduction in the expression of mRNA for
these chemokines by neutrophils after incubation with either
Curdlan or HKC (Figure S6). As expected, no expression of
mRNA for CXCL1 or CXCL2 was detected in T or B cells. These
data support the idea that C. albicans-induced production of
CXCL1 and CXCL2 by neutrophils is strongly dependent on
type I IFN and suggest that the decreased production of these
chemokines by renal infiltrating leukocytes during C. albicans
infection of Ifnar1/mice results from their defective production
by neutrophils in the absence of IFNAR signaling.
IFN-b Production during C. albicans Infection Is
Controlled by DCs through Dectin and Syk Signaling
Our data from in vivo infection experiments in Ifnar1/ mice re-
vealed that type I IFN production is crucial for defense against
C. albicans. In order to determine the contribution of DCs to
type I IFN production through the Dectin-Syk-IRF5 signaling
pathway, C. albicans infection experiments were performed in
CD11c-Cre+/ Sykfl/fl mice, in which DCs are not responsive to
Syk-dependent signaling and consequently are impaired in their
capacity to produce IFN-b through Dectin and Syk. For this pur-
pose, we first analyzed the kinetics of IFN-b production by renal
infiltrating leukocytes after C. albicans infection by real-time
PCR. Our data revealed that IFN-b production was undetectable
at day 2 after infection, peaked at day 3 and was reduced along
the next 24 hr (Figure 6A); IFN-b was not detectable on splenic
DCs from day 2 to day 4 after infection (Figure 6B). On the basis
of these data, we next analyzed IFN-b mRNA expression by
renal infiltrating leukocytes at day 3 postinfection in WT and
CD11c-Cre+/ Sykfl/fl mice. Interestingly, IFN-b production by
renal-infiltrating leukocytes was reduced by around 70% in
CD11c-Cre+/ Sykfl/fl mice (Figure 6C), and this reduction was
not paralleled by a decreased number of infiltrating DCs (Fig-
ure 6D). In conclusion, our data strongly support the idea that,Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc. 1181
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Figure 5. Type I IFN Produced in Response to C. albicans Is Crucial for Defense against Candidiasis
(A) Survival of WT (n = 12) and Ifnar1/ (n = 12) mice infected intravenously with 1 3 105 C. albicans.
(B) Kidney fungal burden of WT (n = 7) and Ifnar1/ (n = 7) mice at day 6 after infection with 1 3 105 C. albicans. Data are expressed as cfu/g kidney.
(C) Kinetics of infiltrating leukocytes (defined as CD45+ cells) after infection with 13 105C. albicans of WT or Ifnar1/mice. Data are expressed as mean ± SD of
four mice per condition.
(D) Absolute number of T, NK, andB cells (defined as CD90+, CD49b+, andCD19+ cells, respectively) in the renal leukocyte infiltrates ofWT or Ifnar1/mice at the
indicated times after infection with 1 3 105 C. albicans. Data are expressed as mean ± SD of four mice per condition.
(legend continued on next page)
Immunity
Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCs
1182 Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc.
C1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
7.0 
8.0 
9.0 
Day2 Day3 Day4 
1.0 
2.0 
3.0 
4.0 
5.0 
6.0 
7.0 
8.0 
9.0 
Day2 Day3 Day4 
Ifn
β (
in
du
ct
io
n 
fo
ld
) 
Ifn
β (
in
du
ct
io
n 
fo
ld
) 
A B
0 
20 
40 
60 
80 
100 
120 
140 
160 
180 
WT 
Ifn
β (
in
du
ct
io
n 
fo
ld
) 
CD11c-cre +/-
Syk fl/fl
**
0 
0.5 
1.0 
1.5 
2.0 
2.5 
WT CD11c-cre +/-
Syk fl/fl
A
bs
ol
ut
e 
nu
m
be
r (
x1
05
)
*D
* *
Figure 6. IFN-b Production in Candida-
Infected CD11c-Cre+/– Sykfl/fl Mice
(A and B) Expression of IFN-b mRNA by purified
leukocyte preparations from renal infiltrates (A) or
purified splenic DCs (B) obtained at the indicated
times after infection with 1 3 105 C. albicans
assessed by real-time PCR, normalized to b-actin.
Data are expressed as induction fold relative to the
expression at day 2 after infection (mean ± SD of
triplicates).
(C) Expression of IFN-b mRNA by purified renal
infiltrating leukocyte preparations from WT or
CD11c-Cre+/ Sykfl/fl mice at day 3 after infection
assessed by real-time PCR, normalized to b-actin.
Data are expressed as induction fold relative to the
expression at day 2 post-infection for WT mice
(mean ± SD of triplicates).
(D) Absolute number of DCs in the renal leukocyte
infiltrates of WT or CD11c-Cre+/ Sykfl/fl mice at
day 3 after infection. DCs were defined as CD11c+
CD11b+ cells after gating out cells expressing
CD90 (T cells), B220 (B cells), CD49b (NK cells),
and Ly-6G (neutrophils). Data are expressed as
mean ± SD of three mice per condition. Significant
differences as determined by the unpaired t test
are indicated *p < 0.05; **p < 0.01. Data are
representative of two independent experiments
with similar results.
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCsafter C. albicans infection, IFN-b production by renal infiltrating
leukocytes is controlled primarily by DCs and, importantly, that
this production of IFN-b by renal infiltrating DCs is essentially
driven by Dectin signaling via Syk.
DISCUSSION
Type I IFN is produced after engagement of cytosolic receptors
or membrane-bound TLR receptors by viral or bacterial com-
pounds through the activation of the transcription factors IRF3
and IRF7 (Trinchieri, 2010), as shown in Figure S7, summarizing
the key signaling pathways emerging from the main type I
IFN-inducing receptors. Fungi, particularly yeasts of the genus
Candida, have also been recently reported to induce IFN-b pro-
duction (Biondo et al., 2011; Bourgeois et al., 2011), but the
mechanism responsible for the transcriptional activation of Ifnb
gene in DCs, during C. albicans infection, is a matter of contro-
versy. In this report we describe a signaling pathway leading to
the production of IFN-b after stimulation of BMDCswith Curdlan,
a Dectin-1 specific ligand that mimics the interaction of this
C-type lectin receptor with b-glucans from C. albicans cell wall.
IFN-b production triggered by Dectin-1 engagement is depen-(E andF)Absolute number ofDCs (E) andneutrophils (F), definedbyflowcytometry
infiltrates of WT or Ifnar1/ mice, at the indicated times after infection with 13 1
(G) Expression of mRNA for CXCL1 and CXCL2 by purified leukocyte preparations
with 13 105 C. albicanswas assessed by real-time PCR, normalized to b-actin. D
WT mice, considering as 1 the average expression for WT mice (mean ± SD of f
(H) Production of CXCL1 and CXCL2 by purified leukocyte preparations from rena
105 C. albicans, analyzed by Luminex. Significant differences as determined by
representative of at least two independent experiments with similar results. Seedent on Syk, Card9, and the transcription factor IRF5, and inde-
pendent of IRF3 and IRF7, as illustrated in Figure S7. To our
knowledge, C-type lectin receptors had not been previously
demonstrated to trigger the production of type I IFN. In addition,
experiments using antibodies against Dectin-2, another Syk and
Card9-dependent C-type lectin receptor recognizing C. albicans
cell wall mannans, revealed that Dectin-2 signaling also contrib-
utes significantly to IFN-b production in response to C. albicans,
a process that therefore results from a dual contribution of
Dectin-1 and Dectin-2 signaling, in agreement with previous
data demonstrating the cooperation of these receptors in
inducing IL-2 and IL-10 production by BMDCs (Robinson et al.,
2009). Importantly, our data based on BMDC stimulation with
Curdlan and HKC demonstrate that IFN-b production in
response to C. albicans is mostly controlled by Dectin-1 and
Dectin-2 signaling with a minor contribution of TLR2 signaling.
Therefore Candida-induced IFN-b production essentially results
from the recognition of C. albicans cell-wall b-glucans by
Dectin-1 and cell-wall mannans by Dectin-2 and TLR2. The dif-
ferential relevance of TLR9 signaling to IFN-b production in
response to Zymosan versus HKC reflects that whereas yeast
DNA is readily exposed in Zymosan preparations and thus hason thebasis ofCD11candLy-6Gexpression, respectively, in the renal leukocyte
05 C. albicans. Data are expressed as mean ± SD of four mice per condition.
from renal infiltrates obtained fromWT or Ifnar1/mice at day 4 after infection
ata are expressed as relative expression of each chemokine in Ifnar1/ versus
our mice per condition).
l infiltrates obtained fromWT or Ifnar1/mice at day 4 after infection with 13
the unpaired t test are indicated *p < 0.05; **p < 0.01; ***p < 0.001. Data are
also Figures S4 to S6.
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCsa major contribution to Zymosan-induced IFN-b production,
CandidaDNA-mediated TLR9 signaling does not contribute sub-
stantially to IFN-b production in response to C. albicans.
Our data revealed that Dectin-1-mediated IFN-b production is
driven by a Syk-Card9-dependent pathway, that has been
demonstrated to activate NF-kB and MAP kinases (Sancho
and Reis e Sousa, 2012), supporting the hypothesis that
Dectin-1 signaling can lead to the activation of two key transcrip-
tional factors required for the assembly of the IFN-b enhanceo-
some, NF-kB, and c-Jun (Panne et al., 2007). IRF3 and IRF7
were also demonstrated to contribute to the IFN-b enhanceo-
some controlling type I IFN production resulting from the activa-
tion of cytosolic or TLR receptors (Trinchieri, 2010). However,
unexpectedly, Dectin-1-induced transcription of the Ifnb gene
required neither IRF3 nor IRF7 but the transcription factor
IRF5. A link between IRF5 and type I IFN production during viral
infections was proposed in studies showing that infection by
viruses, such as Newcastle disease virus (NDV), vesicular sto-
matitis virus (VSV), and herpes simplex virus type 1 (HSV-1),
led to the transcription of Ifna and Ifnb genes, by an IRF5-depen-
dent mechanism (Barnes et al., 2002). Type I IFN production
induced in response to the TLR7 ligand R-848 was also found
to depend on both IRF7 and IRF5 (Schoenemeyer et al., 2005).
More recently,Mycobacterium tuberculosis-induced expression
of IFN-bmRNA inmacrophages has been reported to occur after
recognition of a bacterial muramyl dipeptide by the cytosolic
receptor NOD2 and was largely dependent on IRF5 (Pandey
et al., 2009). In addition, BMDCs were demonstrated to produce
IFN-b after recognition of RNA from Streptococcus pyogenes by
amechanism dependent onMyD88 and IRF5 (Gratz et al., 2011).
The production of IFN-b by DCs in response to fungi, and
particularly to yeasts of the genus Candida, has been described
in two recent reports that proposed different signaling pathways
to explain the transcriptional activation of the Ifnb gene induced
by yeasts. Bourgeois et al. proposed that IFN-b production in
response to Candida glabrata was triggered after engagement
of TLR-7 by fungal RNA and was not affected by Dectin-1 defi-
ciency; unexpectedly, this process appeared to be independent
of IRF3 and IRF7 (Bourgeois et al., 2011). Alternatively, Biondo
et al. reported that C. albicans 90028 strain induced IFN-b pro-
duction by BMDCs after recognition of fungal DNA and proposed
that this occurred by a mechanism partially dependent on TLR-7
and TLR-9 and on IRF-1, IRF3, and IRF7 (Biondo et al., 2011). In
addition, these authors reported that Dectin-1 was not involved
in the production of IFN-b in response to C. albicans yeast parti-
cles. Therefore, these two studies concur in proposing that IFN-b
production in response to Candida was triggered by the activa-
tion of TLR receptors by fungal nucleic acids with no contribution
of Dectin-1 signaling. The divergence between these reports and
our data, proposing a major role for Dectin-1 in IFN-b production
in response to C. albicans SC5314 strain (being the contribution
of TLR signaling secondary), could be due to differences in the
cell-wall composition between the yeast species or strains
used in these studies that may dictate their ability to activate
Dectin-1 signaling. In this regard, Candida glabrata is a nondi-
morphic yeast that is phylogenetically closer to Saccharomyces
cerevisiae than toC. albicans (Kurtzman and Robnett, 1997), and
thus C. albicans and C. glabrata may differ substantially in their
ability to activate Dectin-1 signaling. Interestingly, host defense1184 Immunity 38, 1176–1186, June 27, 2013 ª2013 Elsevier Inc.against two C. albicans strains was found to be differentially
dependent on Dectin-1; whereas this receptor was required for
the induction of antifungal immunity against the SC5314 strain
(Taylor et al., 2007), protective immunity after infection with the
IFO1385 strain was independent of Dectin-1 (Saijo et al., 2007).
The physiological relevance of the production of type I IFN in
response to C. albicans was confirmed by our in vivo studies
revealing that Ifnar1/ mice had a lower survival after infection
with C. albicans that was paralleled by a higher fungal burden
in the kidney, themain target after systemicC. albicans infection.
Our data, demonstrating that type I IFNs contribute to a more
efficient immune response against C. albicans, confirm two pre-
vious reports onC. albicans (Biondo et al., 2011) andCryptocco-
cus neoformans (Biondo et al., 2008) infection that support the
hypothesis that type I IFN had a beneficial effect for antifungal
immunity. However, type I IFN had a deleterious effect during
infection by the fungi Histoplasma capsulatum (Inglis et al.,
2010) orC. glabrata (Bourgeois et al., 2011). In addition, Ifnar1/
mice were recently reported to have an improved survival in
response to C. albicans, although strikingly this increased sur-
vival was not paralleled by a lower fungal burden (Majer et al.,
2012). Type I IFN has also been demonstrated to have opposing
beneficial or detrimental effects on antiviral and antibacterial
immunity depending on the infectious process (Trinchieri,
2010). During viral infections, type I IFNs contribute to host
defense through their antiviral and immunomodulatory proper-
ties, but they can also mediate tissue damage and inflammatory
or autoimmune reactions. Type I IFN can also contribute to pro-
tective antibacterial immunity essentially by blocking intracel-
lular bacterial replication and through the induction of nitric oxide
and proinflammatory cytokines. However, type I IFN production
is often detrimental for defense against bacteria through several
mechanisms. In this regard, type I IFN can increase the suscep-
tibility of T cells and macrophages to apoptosis, interfere with
microbicidal mechanisms, favor bacterial replication, limit T cell
responses, and alter the recruitment and activation of myeloid
cells to the site of infection (Stetson and Medzhitov, 2006).
Our results revealed that IFNAR1 deficiency led to lower sur-
vival after C. albicans infection that was paralleled by a defective
renal neutrophil recruitment and a lower production of the
neutrophil-chemoattractant chemokines CXCL1 and CXCL2.
These findings support that type I IFN plays a crucial role in
defense against C. albicans by promoting the mobilization of
neutrophils to the kidney. Neutrophils are required for an efficient
protection against systemic candidiasis due to their high
capacity to kill C. albicans (Mansour and Levitz, 2002), as
demonstrated by experiments of neutrophil depletion in
C. albicans-infected mice, in which survival was severely
compromised (Dejima et al., 2011). CXCL1 and CXCL2 have a
critical function in the recruitment of neutrophils (Kobayashi,
2006), and interestingly they appear to be highly expressed in
the kidney of C. albicans-infected mice, as revealed by gene
expression microarray analysis (MacCallum, 2009). In this re-
gard, our data suggest that type I IFN controls renal neutrophil
infiltration by controlling the production of CXCL1 and CXCL2
by neutrophils, in contrast to previous evidence on the negative
regulation of these chemokines by type I IFN (Trinchieri, 2010).
More importantly, the experiments revealing that the pro-
duction of IFN-b by renal infiltrating leukocytes was severely
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Dectin-1-Syk-IRF5-Dependent IFN-b Production by DCsreduced in C. albicans-infected CD11c-Cre+/ Sykfl/fl mice, in
which DCs are not responsive to Syk-dependent signaling,
have been decisive to establish the link between the compro-
mised survival of Ifnar1/ mice and the Dectin and Syk-depen-
dent pathway of IFN-b production by DCs. These data support
the hypothesis that most of type I IFN required for protection
against C. albicans was produced by renal-infiltrating inflamma-
tory DCs through Dectin-Syk signaling and that there was only a
minor contribution from DCs through Syk-independent sig-
naling, and/or from the rest of non-DC infiltrating leukocytes, to
type I IFN production during C. albicans infection.
In conclusion, the data presented in this report demonstrate
that the production of type I IFN by DCs induced by
C. albicans is essentially controlled by a Dectin-1-mediated
signaling pathway, dependent on Syk, Card9 and IRF5. The
existence of this pathway extends the physiological relevance
of Dectin-1-mediated signaling, particularly in the context of
the induction of antifungal immunity because, in addition to
driving the synthesis of cytokines that are essential for the induc-
tion of Th17 cell responses, it triggers the production of IFN-b
that, as revealed by our data, is crucial for defense against
C. albicans.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (10–12 weeks old) female mice were purchased from Harlan
(Bicester, UK). Ifnar1/ mice were kindly provided by Dr. U. Kalinke (Center
for Experimental and Clinical Infection Research, Hannover, Germany).
CD11c-Cre+/ Sykfl/fl mice and Clec4e/ mice were provided by Dr. D. San-
cho (Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain).
C57BL/6, Ifnar1/, and CD11c-Cre+/ Sykfl/fl mice were housed at the animal
facility of Centro Nacional de Biotecnologı´a-CSIC, Madrid, Spain. Card9/
mice were generated by Dr. J. Ruland (Technische Universita¨t Mu¨nchen,
Mu¨nchen, Germany). Bone marrow from Clec7a/ mice was generously
provided by Dr. G. Brown (University of Aberdeen, Aberdeen, UK), from Tlr2/
mice by Dr. M. Fresno (Centro de Biologı´a Molecular Severo Ochoa-CSIC-
UAM, Madrid, Spain), from Tlr9/ mice by Dr. J. Pardo (Universidad de
Zaragoza, Spain), from Irf3/ and Irf7/mice by Dr. T. Decker (Max F. Perutz
Laboratories, Vienna, Austria) and from Irf5/ mice by Dr. T. Mak (University
Health Network, Toronto, Ontario). All the experiments were approved by the
Animal Care and Use Committee of the Centro Nacional de Biotecnologı´a-
CSIC, Madrid.
C. albicans
C. albicans (strain SC5314; kindly provided by Prof. C. Gil, Complutense Uni-
versity, Madrid) was grown on YPD plates (Sigma, St Louis, MO) at 30C. HKC
were obtained by incubation of C. albicans, strain SC5314, for 2 hr at 65C.
Stimulation of BMDCs and BMMs
BMDCs or BMMs obtained as described in Supplemental Information, were
rested for 6 hr in complete cell culture medium and subsequently stimulated
at the indicated times with 100 ng.ml1 LPS from Escherichia coli (Sigma),
10 mg.ml1 Curdlan (Wako chemicals, Neuss, Germany), 10 mg.ml1 Zymosan
(Invivogen, San Diego, CA), or 5 3 105 HKC. To address the contribution of
Dectin-2 to IFN-b production, we incubated BMDCs for 2 hr with 10 mg.ml1
blocking anti-Dectin-2 antibodies (clone D2.11E4) kindly provided by Dr. P.
Taylor (Cardiff Institute of Infection and Immunity, Cardiff, UK) or isotype-
matched control antibodies, and subsequently stimulated as indicated above.
The phenotypic analysis of BMDCs and BMMs was performed by flow cytom-
etry. IFN-b mRNA expression by BMDCs and BMMs was analyzed by real-
time PCR. RelA, c-Jun, and IRF3 activation on BMDCs was assessed by
immunoblot. Flow cytometry, real-time PCR, and immunoblot methods are
described in Supplemental Information.C. albicans In Vivo Infection
Mice were intravenously infected with 13 105 C. albicans and monitored daily
for health and survival following the institutional guidance. Kidney fungal
burden was determined at day 6 after infection by plating organ homogenates
in serial dilutions on YPD plates; colony-forming units (cfu) were counted after
growth for 48 hr at 30C. Flow cytometry analysis of renal leukocyte infiltrates
was performed on cell suspensions obtained from organ homogenates that
were digestedwith 0.5 mg.ml1 of collagenase A (Roche,Mannheim, Germany)
for 10 min at 37C and filtered through 40 mm cell strainers (BD PharMingen,
San Diego, CA). The phenotypic analysis of renal leukocyte infiltration was
performed by flow cytometry as described in Supplemental Information. For
real-time PCR and Luminex analyses, performed as described in Supple-
mental Information, renal infiltrating leukocytes were purified from kidney
cell suspensions by centrifugation on a gradient of Ficoll-Paque Plus (GE
Healthcare, Uppsala, Sweden) and immunomagnetic positive selection after
incubation with biotin-conjugated anti-CD45 and streptavidin-conjugated
microbeads. Splenic DCs were purified by immunomagnetic positive selection
after incubation with biotin-conjugated anti-CD11c and streptavidin-conju-
gated microbeads.
Cytokine Detection
IFN-b production was quantified by using the Verikine mouse IFN beta ELISA
kit (PBL, Piscataway, NJ). IFN-b production values for unstimulated controls
were below the detection level of this ELISA kit (15.6 pg/ml) for all the experi-
ments analyzing IFN-b production. CXCL1 and CXCL2 production was
analyzed by Luminex technology as described in Supplemental Information.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, two tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2013.05.010.
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